Three strategies for managing loss of exclusivity successfully
Consultant, Claire Taylor explains why you should be strategically planning your LOE strategy years in advance.
“Patent losses could sink Allergan”.
1
2
3
4
It’s no wonder “loss of exclusivity (LOE)” or “the patent cliff” is an ominous prospect for drug manufacturers – shrouded in the threat of job losses and falling share prices.
However, for society patent expirations are fundamentally a good thing – crucial to maintaining the balance between encouraging innovation and improving opportunities for all.
Loss of exclusivity (LOE) is a natural milestone in a drug’s lifecycle. Focused and effective late lifecycle management can preserve meaningful value for the brand.
Out digital downloads by selling access to massive music catalogs stored in the cloud. i think most people in the music business have no idea what the future will be. there s all these technological challenges to profitability, and they don t know how to combat that. while researching treatments for high blood pressure and heart disease, the drug company pfizer accidentally develops a life-changing little blue pill. in 1998 viagra is approved by the fda. it turns out there was a side effect that a lot of the initial patients had. they developed erections and the pharmaceutical companies quickly realized that s a much better place for us to market than just another blood pressure pill. viagra was a big deal because it treated erectile function and